Meridian Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$535K Buy
5,834
+224
+4% +$19.6K 0.06% 65
2026
Q1
$478K Buy
+5,610
New +$500K 0.07% 69
2021
Q4
Sell
-4,087
Closed -$308K 84
2021
Q3
$308K Buy
4,087
+22
+0.5% +$1.75K 0.07% 54
2021
Q2
$330K Hold
4,065
0.08% 50
2021
Q1
$320K Sell
4,065
-358
-8% -$28.1K 0.1% 49
2020
Q4
$378K Buy
4,423
+3
+0.1% +$248 0.16% 38
2020
Q3
$341K Sell
4,420
-38
-0.9% -$2.9K 0.17% 36
2020
Q2
$327K Buy
4,458
+3
+0.1% +$213 0.18% 37
2020
Q1
$296K Buy
4,455
+4
+0.1% +$282 0.18% 41
2019
Q4
$306K Buy
+4,451
New +$303K 0.19% 37

Other funds holding CL

Meridian Wealth Partners's CL Position: Q2 2026 in Review

Meridian Wealth Partners increased its Colgate-Palmolive (CL) stake by 4% in Q2 2026, buying an estimated $19.6K and bringing the position to 5,834 shares worth $535K. The position accounts for 0.06% of the portfolio, ranked #65.

Meridian Wealth Partners first reported a position in CL in Q4 2019 and has held it in 10 quarters since. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Meridian Wealth Partners held 5,834 shares of Colgate-Palmolive worth $535K as of Q2 2026.
  • Meridian Wealth Partners bought 224 Colgate-Palmolive shares in Q2 2026, an estimated $19.6K.
  • Colgate-Palmolive made up 0.06% of Meridian Wealth Partners's portfolio in Q2 2026, its #65 holding.
  • Meridian Wealth Partners first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 10 quarters since.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Meridian Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.